FAGA Is Not a Miniature Version of Male AGA: Reading Female Pattern Hair Loss Through the Ludwig Classification and Stem Cell Conditioned Media2026.07.01

You may have heard the phrase, “FAGA is the female version of AGA.” In real clinical practice, however, female pattern hair loss looks quite different from male androgenetic alopecia. The distribution of thinning, the pace of progression, and the underlying hormonal environment all point to a separate disease. Treating female pattern hair loss as a “miniature version of male AGA” within the same framework risks choosing the wrong therapy and missing the tests that actually matter.

Many women with thinning hair are prescribed the same drugs as men at a general dermatology clinic and, after several months, still feel that nothing has changed. One reason is that the treatment plan does not reflect the follicular reactivity specific to female pattern hair loss, or the endocrine background unique to the female body. This article organizes how to approach women’s hair loss through the lens of the Ludwig classification and the frontal-hairline sparing pattern.

How Female Pattern Hair Loss Differs From Male AGA

The first point to understand is the difference in progression pattern. Male AGA typically follows an “M-shape plus crown” pattern, with recession at the frontal hairline and thinning at the vertex. Female pattern hair loss, on the other hand, is centered on a diffuse reduction of volume that spreads from the part line into the central scalp.

The Map of Shedding Is Different

In men, the follicles themselves are lost, creating fully bald patches. In FAGA, the follicles remain in place, but each hair becomes finer and shorter through a process called miniaturization. Part the hair along the central line at the crown, and a widening translucency of the scalp becomes visible. This is the classic sign of female pattern hair loss. By the time the scalp visually “suddenly looks more exposed,” hair diameter has typically been thinning quietly for years.

A Multifactorial Hormonal Background

In male AGA, dihydrotestosterone (DHT) plays the leading role. Female pattern hair loss, by contrast, is multifactorial. Estrogen decline around menopause, thyroid dysfunction, iron and ferritin deficiency, effects of oral contraceptives and HRT, relative androgen excess from polycystic ovary syndrome (PCOS), and sudden postpartum hormonal shifts can act alone or in combination to alter the follicular environment. Simply “suppressing male hormones” is not enough — this is precisely what makes treatment of female pattern hair loss more nuanced.

Reading Progression With the Ludwig Classification

The Ludwig classification is the internationally used scheme for staging female pattern hair loss. Grade I represents subtle translucency around the part line, Grade II a moderate loss of volume spreading beyond the part, and Grade III advanced diffuse thinning across the entire vertex.

Frontal Hairline Sparing — A Signature Pattern

A key feature of the Ludwig classification is the assumption that the frontal hairline is preserved. Large, M-shape recession like in men is rare, and the very front row of the hairline often remains intact to the end. This frontal sparing is one reason why patients often fail to notice their own thinning in the mirror. Many women only realize when a family member says, “Your part has widened,” or “I can see your scalp from behind” — and by that point they are often already at Grade II.

Don’t Forget the Christmas Tree Pattern

Among Asian women, there is another well-known pattern: hair loss spreading radially from the central front scalp, called the “Christmas tree pattern.” It cannot be fully captured by the Ludwig classification alone, and clinicians should keep it in mind when designing treatment. Classifications are common clinical language, but in reality progression is a gradient.

Stem Cell Conditioned Media as an Option for Female Pattern Hair Loss

Because the hormonal background of female hair loss is complex, we cannot make finasteride or dutasteride the centerpiece of therapy as we do in men. For women of reproductive age, anti-androgen medications also require caution. That is why approaches that act on the “microenvironment” of the follicle itself hold an important place in female pattern hair loss management.

What Stem Cell Conditioned Media Contributes

Stem cell conditioned media contains growth factors (VEGF, IGF-1, HGF, FGF and others), cytokines, and exosomes carrying intercellular signaling molecules. These are thought to support angiogenesis around the follicle, suppress microinflammation, and help maintain the activity of dermal papilla cells — in other words, they contribute to building an environment in which follicles can function healthily. This is not a magic replacement for miniaturized follicles, but it can be a stimulus that nudges follicles resting in the telogen phase back into anagen.

For guidelines on AGA and female pattern hair loss and the classification of hair diseases, please also refer to the Japanese Dermatological Association. Related columns from our clinic are collected here: see our hair regenerative medicine column archive.

Treatment Is a Long Game — Evaluate Every 3 to 6 Months

Female pattern hair loss does not change dramatically in a few weeks. The hair cycle (anagen, catagen, telogen) runs on a scale of months to years, so we assess the effect of stem cell conditioned media at three months at the earliest, more commonly at around six months, using standardized photographs, changes in part-line translucency, and hair diameter measurements. Some women experience “shedding” between weeks two and eight of treatment — this is a normal response of telogen hairs being pushed out, not a sign of failure. Establishing a rhythm of records and standardized follow-up is, in the end, the faster route to results.

Summary

Female pattern hair loss is not a scaled-down version of male AGA. Its pattern of progression and its hormonal background differ, and it should be understood as a distinct disease. Grasping your own stage with the Ludwig classification, taking the frontal-sparing pattern into account, and building a treatment plan with your physician that combines oral therapy, topical therapy, lifestyle care, and stem cell conditioned media — this is a realistic strategy for living with thinning hair over the long term. Rather than saying “male drugs did not work for me,” the first step is to choose therapy “designed for female pattern hair loss.”

──────────────

Medical Supervisor: Shin Moriwaki, MD

Member of the Japan Society of Aesthetic Surgery (JSAS)

Member of the American Academy of Aesthetic Medicine

ECFMG Certificate (US medical license qualification)

──────────────

📍AVAN TOKYO 銀座 毛髪再生医療

AVAN TOKYO Ginza Hair Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries welcome via DM / LINE / Website / Phone.